Dr Pepper Snapple Group Inc. said its normalized net income for the fourth quarter came to 95 cents per share, compared with the S&P Capital IQ consensus estimate of $1.06 per share.
EPS fell year over year from 98 cents.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was $176.3 million, a decrease of 5.4% from $186.3 million in the prior-year period.
The normalized profit margin declined to 11.2% from 12.0% in the year-earlier period.
Total revenue climbed on an annual basis to $1.58 billion from $1.55 billion, and total operating expenses increased on an annual basis to $1.25 billion from $1.22 billion.
Reported net income decreased 10.4% year over year to $166.1 million, or 90 cents per share, from $185.4 million, or 97 cents per share.
For the year, the company's normalized net income totaled $4.33 per share, compared with the S&P Capital IQ consensus normalized EPS estimate of $4.41.
EPS rose from $3.87 in the prior year.
Normalized net income was $808.8 million, a rise from $744.4 million in the prior year.
Full-year total revenue rose year over year to $6.44 billion from $6.28 billion, and total operating expenses totaled $5.00 billion, compared with $4.98 billion in the year-earlier period.
The company said reported net income increased year over year to $847.2 million, or $4.54 per share, in the full year, from $763.8 million, or $3.97 per share.
